Europe Digital Health Market Overview
Market Size in 2024: USD 117.77 Billion
Market Forecast in 2033: USD 292.95 Billion
Market Growth Rate: 10.7% (2025-2033)
According to the latest report by IMARC Group, the Europe digital health market size was valued at USD 117.77 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 292.95 Billion by 2033, exhibiting a CAGR of 10.7% from 2025-2033.
Europe Digital Health Industry Trends and Drivers:
Driven by the growing penetration of cutting-edge technologies in the medical industry, the European digital health market is growing quickly. Technological advancements in wearable health devices, remote monitoring systems, and telemedicine are raising operating efficiency and improving patient care. By using digital tools more extensively, healthcare professionals all around may provide more customized treatments and remotely monitor patient conditions in real-time. These developments are both making healthcare more accessible and drastically lowering the demand for physical visits, therefore increasing ease and lowering costs. Furthermore improving diagnoses, forecasting health outcomes, and customizing treatment plans, the continuous developments in artificial intelligence (AI) and machine learning all help to create a better healthcare experience for patients.
Strong legislative support for telehealth services and data privacy safeguards is also driving the uptake of digital health solutions in Europe. Especially as populations keep aging, governments all over the region are realizing how vital digital health technologies are in enhancing public health systems. Regulatory systems are changing to support telehealth and telemedicine, hence increasing patient and healthcare practitioner access. Moreover, patient data security continues to be a main concern, with rules like the General Data Protection Regulation (GDPR) guaranteeing that digital health systems uphold top levels of security and privacy. As healthcare players become more sure in embracing new technologies, this regulatory assistance is fostering the widespread acceptance and use of digital health tools.
Cost-reduction techniques are increasingly driving the widespread acceptance of digital health solutions across Europe as the market expands. Rising healthcare expenses cause patients and providers to look increasingly for means to lower costs while still keeping high standards of care. By allowing remote consultations and enhancing patient management, digital health technologies are showing to be effective cost-saving instruments. Moreover, bespoke medicine is receiving increasing attention; digital platforms help to gather and examine patient data to provide customized therapies. Healthcare professionals and patients—who are growingly searching for therapies more tailored to their personal needs—are finding this emphasis on customized care resonating with both of them. These elements are together setting Europe's digital health industry for ongoing expansion and providing a host of chances over the next few years.
Download sample copy of the Report: https://www.imarcgroup.com/europe-digital-health-market/requestsample
Europe Digital Health Industry Segmentation:
The report has segmented the market into the following categories:
Analysis by Type:
- Telehealth
- Medical Wearables
- EMR/EHR Systems
- Medical Apps
- Healthcare Analytics
- Others
Analysis by Component:
- Software
- Hardware
- Service
Country Analysis:
- Germany
- France
- United Kingdom
- Italy
- Spain
- Others
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Latest News and Developments:
- April 18, 2024: SPMS launched a new initiative called OurHealth@PT to improve and expand MyHealth@EU services in Portugal, including inclusion of laboratory results and increases service coverage across pharmacies and hospitals. Co-funded through the EU under the new EU4Health 2021-2027 programme, the initiative supports cross-border digital health services with secure access to health data to strengthen Portugal's place in the European Health Data Space.
- April 10, 2024: Dr. Reddy's Laboratories launched the FDA-approved migraine management wearable device Nerivio in Germany, marking its entry into digital therapeutics in Europe. After being first showcased at major neurology events in 2024, it will expand to Spain and the UK. The company continues its partnership with Theranica, with which it entered into a deal to market Nerivio globally in a bid to address millions suffering from migraines worldwide.
Key highlights of the Report:
- Market Performance (2019-2024)
- Market Outlook (2025-2033)
- COVID-19 Impact on the Market
- Porter’s Five Forces Analysis
- Strategic Recommendations
- Historical, Current and Future Market Trends
- Market Drivers and Success Factors
- SWOT Analysis
- Structure of the Market
- Value Chain Analysis
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Ask analyst for your customized sample: https://www.imarcgroup.com/request?type=report&id=10917&flag=C
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
